Ling Lu

Ling Lu practices at Peyman Younesi MD in Flushing, New York.

Ling Lu's NPI, 1447562376, was assigned on July 8, 2010. Ling Lu holds New York license 281317.

Ling Lu's primary practice is Peyman Younesi MD, at 33-7 164th St, Flushing, NY 11358 in Queens County. The practice phone is (718) 709-0940.

Ling Lu's primary practice is Peyman Younesi MD in Flushing, New York. The medical group on file is Midtown East Medical Services, PC. Dmand AI also links Ling Lu to 2 more physician offices, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Ling Lu practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Ling Lu's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dmand AI has Ling Lu's licenses on file in 2 states: New York and Missouri.

CMS data shows 2,419 Medicare services from Ling Lu across 8 procedure codes in 2024, for 164 Medicare patients. Medicare paid $217,632 for them. Every service was in an office.

CMS counts 164 Medicare patients who saw Ling Lu in 2024. The largest group is 65 to 74, with 71 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 82% are also on Medicaid. Their average risk score is 2.82, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Ling Lu's median patient age at 56, with 50% women.

In 2024, Ling Lu wrote 7,156 Medicare Part D claims for 267 patients. 82% of them were for generic drugs. CMS names the drug for 6,334 of them, across 146 drugs with 11 or more claims each, at $631,746 in total drug cost. In 2023, CMS named 5,293 claims across 121 drugs.

Ling Lu accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Ling Lu as offering telehealth.

Dmand AI links 484 papers to Ling Lu, published from 2009 to 2025. 2021 was the busiest year, with 33. The most frequent topics are Aspergillus fumigatus, Fungal Proteins and Signal Transduction. Ling Lu has published most often in Appl Environ Microbiol. Ling Lu's most frequent co-authors are Cheng Cheng, Ping Wang, PTA and Teng Lu.

CMS Open Payments shows 213 general payments to Ling Lu from 24 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Amgen Inc. paid the most, $3,175.